ES2170799T3 - Metodo y medicina para aliviar los efectos del desfase horario (jet lag). - Google Patents

Metodo y medicina para aliviar los efectos del desfase horario (jet lag).

Info

Publication number
ES2170799T3
ES2170799T3 ES95924757T ES95924757T ES2170799T3 ES 2170799 T3 ES2170799 T3 ES 2170799T3 ES 95924757 T ES95924757 T ES 95924757T ES 95924757 T ES95924757 T ES 95924757T ES 2170799 T3 ES2170799 T3 ES 2170799T3
Authority
ES
Spain
Prior art keywords
relief
medicine
effects
jet lag
time scroll
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95924757T
Other languages
English (en)
Inventor
Bonnie Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2170799T3 publication Critical patent/ES2170799T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

LA GALANTAMINA Y O COMPUESTO SALINO ACEPTABLE FARMACEUTICAMENTE SE UTILIZA PARA ALIVIAR LOS SINTOMAS ASOCIADOS A LOS TRASTORNOS DE MICCION U OTRA DISFUNCION DEL "RELOJ INTERNO".
ES95924757T 1994-07-01 1995-06-30 Metodo y medicina para aliviar los efectos del desfase horario (jet lag). Expired - Lifetime ES2170799T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/269,821 US5585375A (en) 1994-07-01 1994-07-01 Method for alleviating jet lag

Publications (1)

Publication Number Publication Date
ES2170799T3 true ES2170799T3 (es) 2002-08-16

Family

ID=23028794

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95924757T Expired - Lifetime ES2170799T3 (es) 1994-07-01 1995-06-30 Metodo y medicina para aliviar los efectos del desfase horario (jet lag).

Country Status (11)

Country Link
US (1) US5585375A (es)
EP (1) EP0764025B1 (es)
JP (1) JPH10506097A (es)
AT (1) ATE214278T1 (es)
AU (1) AU694247B2 (es)
CA (1) CA2193473A1 (es)
DE (1) DE69525841T2 (es)
DK (1) DK0764025T3 (es)
ES (1) ES2170799T3 (es)
PT (1) PT764025E (es)
WO (1) WO1996001113A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1738800A (en) * 1998-11-23 2000-06-13 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
AU2004242546B2 (en) * 1998-11-23 2008-05-15 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
AU2504200A (en) * 1999-01-11 2000-08-01 Atanas Russinov Djananov Herbal supplement for increased muscle strength and endurance for athletes
US8603546B2 (en) * 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
JP2007502297A (ja) * 2003-08-13 2007-02-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ コリンエステラーゼ阻害剤を用いる睡眠障害の処置
US20050191349A1 (en) * 2003-12-31 2005-09-01 Garth Boehm Galantamine formulations
US20050142193A1 (en) * 2003-12-31 2005-06-30 Lijuan Tang Galantamine formulations
EP3628315A1 (en) 2018-09-28 2020-04-01 Université de Caen Normandie Combination of acetylcholinesterase inhibitor and 5-ht4 receptor agonist as neuroprotective agent in the treatment of neurodegenerative diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0584185T3 (da) * 1991-05-14 2000-02-07 Ernir Snorrason Behandling af træthedssyndrom med cholinesteraseinhibitorer

Also Published As

Publication number Publication date
CA2193473A1 (en) 1996-01-18
JPH10506097A (ja) 1998-06-16
ATE214278T1 (de) 2002-03-15
PT764025E (pt) 2002-07-31
AU694247B2 (en) 1998-07-16
DE69525841T2 (de) 2002-10-24
WO1996001113A1 (en) 1996-01-18
AU2914495A (en) 1996-01-25
EP0764025B1 (en) 2002-03-13
DK0764025T3 (da) 2002-05-21
EP0764025A4 (en) 1999-06-02
US5585375A (en) 1996-12-17
EP0764025A1 (en) 1997-03-26
DE69525841D1 (de) 2002-04-18

Similar Documents

Publication Publication Date Title
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
HK1007102A1 (en) Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
LU91205I2 (fr) Ciclesonide et ses dérivés pharmaceutiquement acceptables (alvesco)
LU88750I2 (fr) VENLAFAXINE et ses dérivés pharmaceutiquement acceptables
LU91039I2 (fr) Proteq flu et ses dérivés pharmaceutiquement acceptables
LU90736I2 (fr) Agenerase-amprenavir et ses d-riv-s pharmaceutiquement acceptables
DK120390A (da) Nasal administration af benzodiazepinhypnotika
CA2133966A1 (en) Ocular androgen therapy in sjogren's syndrome
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
ATE113839T1 (de) Arzneimittel gegen impotenz.
ES2170799T3 (es) Metodo y medicina para aliviar los efectos del desfase horario (jet lag).
LU90844I2 (fr) es Riamet et ses d-riv-s pharmaceutiquement acceptabl
IT8848118A0 (it) Impiego di uridina nel trattamento farmacologico di disturbi dovuti ad alterato equilibrio dopaminergico
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
UA19756A1 (uk) Спосіб одержаhhя піперазиhілалкіл-3(2h)піридазиhоhів або їх фармацевтичhо прийhятих солей
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
IT1249034B (it) Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
CA2003856A1 (en) Therapeutic agent for renal disorders
FR2640282B1 (fr) Cristallisation d'un melange aqueux de fructose et d'alcool
ITRM910519A0 (it) Collirio per il trattamento della ipertensione oculare
SE8402702D0 (sv) Anvendning av ett specifikt tumorassocierat antigen i hapten, nemligen fukosylsialosylgangliotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
IT8948660A0 (it) Farmaco attivo nel ripristino della plasticita' neuronale

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 764025

Country of ref document: ES